circulating-tumor-dna

Documents about circulating-tumor-dna

• Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer#1351680ClinicalTrials.gov
• Circulating Tumor DNA After Neoadjuvant Chemotherapy#1466247ClinicalTrials.gov
• Circulating Tumor Cells and Tumor DNA in HCC and NET#917226ClinicalTrials.gov
• Circulating Tumor DNA in Soft Tissue Sarcoma#1309158ClinicalTrials.gov
• DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer#803355ClinicalTrials.gov
• Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer#1060236ClinicalTrials.gov
• Circulating Tumor DNA in Melanoma Patients#1165073ClinicalTrials.gov
• Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.#1486566ClinicalTrials.gov
• Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)#856970ClinicalTrials.gov
• IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer#895603ClinicalTrials.gov
• Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer#390901ClinicalTrials.gov
• Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer#917494ClinicalTrials.gov
• Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer#872470ClinicalTrials.gov
• Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for Non-metastatic Colorectal Cancer#912238ClinicalTrials.gov
• Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer#1246327ClinicalTrials.gov
• Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy#1377553ClinicalTrials.gov
• Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)#882317ClinicalTrials.gov
• Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung Cancer#1214114ClinicalTrials.gov
• Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO)#904744ClinicalTrials.gov
• Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer#1246242ClinicalTrials.gov
• CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01#833317ClinicalTrials.gov
• Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma#827020ClinicalTrials.gov
• Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients#1183515ClinicalTrials.gov
• CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer#854979ClinicalTrials.gov
• Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer#1292941ClinicalTrials.gov
• Multiplex Analysis of Circulating Tumor DNA#865915ClinicalTrials.gov
• Detection of Circulating Tumor DNA Through Liquid Biopsies in Ovarian Cancer Patients and Evaluation of Prognostic and Predictive Values of Circulating Tumor DNA Assay.#1262379ClinicalTrials.gov
• The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease#410145Scholar Commons
• LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients#918999ClinicalTrials.gov
• Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung Cancer#1310102ClinicalTrials.gov
• Rarecells Molecular Biomarkers for Early Detection of Lung Cancer#1397999ClinicalTrials.gov
• Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma#897395ClinicalTrials.gov
• Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study#1261991ClinicalTrials.gov
• Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients#1378419ClinicalTrials.gov
• Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer#858097ClinicalTrials.gov
• Liquid Biopsy in Paraneoplastic Neurological Syndromes#882590ClinicalTrials.gov
• Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer#894749ClinicalTrials.gov
• Detection of Tumor Recurrence via Circulating Tumor DNA Profiling in Patients with Localized Lung Cancer: Clinical Considerations and Challenges#178213HAL (France)
• PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA#1101803ClinicalTrials.gov
• Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients#1047705ClinicalTrials.gov
• WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC#234423ClinicalTrials.gov
• EUS Guided HVA and PVA for Circulating Tumor DNA in Patients#918755ClinicalTrials.gov
• CIrCuLAting Dna ESr1 Gene Mutations Analysis#980316ClinicalTrials.gov
• Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients#178233HAL (France)
• Galleri® in the Medicare Population.#895113ClinicalTrials.gov
• The Value of ctDNA on Chemotherapy Efficacy for mCRC#1431141ClinicalTrials.gov
• Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers#806495ClinicalTrials.gov
• ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer#845546ClinicalTrials.gov
• Circulating Tumor DNA in High Risk Localized Prostate Cancer#896385ClinicalTrials.gov
• The Circulating Cell-free Genome Atlas Study#862898ClinicalTrials.gov